Immune Mechanisms Regulating Cardiac Remodeling
调节心脏重塑的免疫机制
基本信息
- 批准号:10557183
- 负责人:
- 金额:$ 73.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAntibodiesB-Cell ActivationB-LymphocytesBlood VesselsCardiacCardiac MyocytesCardiovascular DiseasesCause of DeathCell Culture TechniquesCellsCoculture TechniquesCytometryDataDevelopmentDisease ProgressionEndothelial CellsExerciseGeneticGoalsGrowthHealthHeartHeart HypertrophyHeart InjuriesHeart failureHospitalizationHypertensionHypertrophyImageImmuneInjuryInterventionLabelMacrophageMacrophage ActivationMediatingMyocardialMyocardiumNatural regenerationPathologicPathway interactionsPhasePhysiologicalPlayPregnancyPreventionProcessProductionProliferatingResearchRoleSignal PathwaySocietiesStressSurvival RateT-LymphocyteTechniquesTherapeuticTissuesUnited StatesWorkangiogenesiscopingexperimental studygene regulatory networkheart functionin vivoinnovationinnovative technologiesinsightmonocytemouse modelnovel therapeuticspressurepreventrecruitresponsesingle-cell RNA sequencingtreatment strategy
项目摘要
Summary
Cardiovascular disease is the number cause of death in the United States. Most cardiovascular diseases are
associated with an increase in myocardial mass or cardiac hypertrophy. The heart responds to exercise and
other stress through an increase in cardiomyocyte in size in order to produce more force and cope with the
increased demand. In addition to signaling pathways that are activated within cardiomyocytes, other cellular
changes occur in response to cardiac stress. Some of these changes are adaptive but others are maladaptive.
Although many therapies are available for heart failure, we are still not able to prevent maladaptive changes in
response to stress. Prevention of maladaptive remodeling can lead to the ultimate avoidance of heart failure. We
have acquired preliminary data using innovative technologies showing that macrophages and B cells are
activated in the early adaptive phase in response to cardiac stress. Our hypothesis is that cardiac resident
macrophages promote adaptive, compensatory remodeling during cardiac stress in a process that is regulated
by B cells. Based on our preliminary findings, we are proposing to determine the role of macrophages in the
early adaptive phase of cardiac remodeling during pathological and physiological stress (Aim 1), investigate the
origins and mechanisms of resident macrophage activation during hypertrophy (Aim 2), and identify the
mechanisms by which B cells influence macrophage function during cardiac stress (Aim 3). Throughout the
proposal we will use innovative techniques, such as single-cell RNA sequencing and advanced imaging
strategies, to probe the role of macrophages and B cells in cardiac remodeling. The ultimate goal of the current
proposal is to identify a possible adaptive role of macrophage early during the remodeling process. Using these
discoveries, future research will focus on developing novel therapeutics to enhance adaptive remodeling and
inhibiting maladaptive remodeling. Given the impact of cardiovascular disease on overall health, this proposal
holds great promise for reducing the burden of cardiovascular disease on our society.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xavier Revelo其他文献
Xavier Revelo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xavier Revelo', 18)}}的其他基金
Mechanisms of B Cell Pathogenicity in Non-Alcoholic Fatty Liver Disease
B细胞在非酒精性脂肪肝中的致病机制
- 批准号:
10434834 - 财政年份:2019
- 资助金额:
$ 73.64万 - 项目类别:
Mechanisms of B Cell Pathogenicity in Non-Alcoholic Fatty Liver Disease
B细胞在非酒精性脂肪肝中的致病机制
- 批准号:
10205056 - 财政年份:2019
- 资助金额:
$ 73.64万 - 项目类别:
Mechanisms of B Cell Pathogenicity in Non-Alcoholic Fatty Liver Disease
B细胞在非酒精性脂肪肝中的致病机制
- 批准号:
10624263 - 财政年份:2019
- 资助金额:
$ 73.64万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 73.64万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 73.64万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 73.64万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 73.64万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 73.64万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 73.64万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 73.64万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 73.64万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 73.64万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 73.64万 - 项目类别: